|
No recent follow-up data from BCIRG006?
Hello everyone, I just completed treatment for Her2 positive cancer in my right breast. I chose to have a lumpectomy, followed by TCH chemotherapy (Taxotere, Carboplatin, Herceptin), and radiation. For me, the difficult choice was whether to use the TCH chemo regimen or the more well-proven ACTH. I chose TCH to hopefully avoid the potential heart problems associated with Adriamycin. I expected that by now there would be additional follow-up data released on the BCIRG006 study which supported the use of TCH. But no more follow-up data has been released since the 2006 data. What does this mean? I am curious to know how BCIRG006 participants are doing after two more years have passed. Mary Ann
|
Threaded Mode